Dr. Kirby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 University Drive
Mail Code HU14
Hershey, PA 17033Phone+1 717-531-8307
Education & Training
- University of Virginia School of MedicineClass of 2004
Certifications & Licensure
- PA State Medical License 2008 - 2024
- American Board of Dermatology Dermatology
Clinical Trials
- Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment Start of enrollment: 2022 Oct 13
Publications & Presentations
PubMed
- Advances in Hidradenitis Suppurativa Pathogenesis and Therapies from the Symposium on HS Advances 2023.Sarah Park, Alexis Bell, Ruby Gibson, Rahul Masson, Steven Daveluy
The Journal of Investigative Dermatology. 2024-08-01 - 1 citationsTrends in antibiotic prescriptions for hidradenitis suppurativa from 2015 to 2021.Mikael Horissian, Christen Samaan, Austin Cohrs, Joslyn Kirby
The British Journal of Dermatology. 2024-06-20 - Uncovering the burden of hidradenitis suppurativa misdiagnosis and underdiagnosis: a machine learning approach.Joslyn Kirby, Katherine Kim, Marko Zivkovic, Siwei Wang, Vishvas Garg
Frontiers in Medical Technology. 2024-01-01
Journal Articles
- Recognizing the Effects and Disparities of Pediatric Hidradenitis SuppurativaJoslyn S Kirby, Andrea L Zaenglein, JAMA Dermatology
Press Mentions
- Incyte Announces 52-Week Results from Phase 2 Study Evaluating Povorcitinib (INCB54707) in Patients with Hidradenitis SuppurativaFebruary 10th, 2023
- Clinical Challenge: Managing Pain in Hidradenitis SuppurativaAugust 27th, 2021
- Differences Between Children and Adults with Hidradenitis SuppurativaAugust 11th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: